Thomas Tu is Chief Medical Officer at Inari Medical, Inc. (NARI). They have made 25 open-market trades across 1 company since 2020, most recently 2025-02-19.
CIK 0001806426
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $534K since 2020, against 24 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| NARI | 478,767 | $38.3M |
Shares reported on the most recent Form 4, priced at the 2025-02-19 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NARI | SELL · 10b5-1 | 2024-12-10 | 2024-12-12 | $55.00 | $220K | -4.8% | +40.8% | N/A |
| NARI | SELL · 10b5-1 | 2024-07-16 | 2024-07-18 | $55.16 | $384K | -5.5% | -9.6% | -19.5% |
| NARI | SELL · 10b5-1 | 2024-07-15 | 2024-07-16 | $55.09 | $1.5M | -6.5% | -13.7% | -26.7% |
| NARI | SELL | 2023-11-16 | 2023-11-17 | $59.82 | $3.0M | +4.4% | +14.6% | +3.2% |
| NARI | SELL | 2023-08-16 | 2023-08-18 | $66.10 | $3.3M | +8.9% | +3.6% | -7.5% |
| NARI | SELL | 2023-05-16 | 2023-05-18 | $70.00 | $3.4M | -8.8% | -11.6% | -2.0% |
| NARI | SELL | 2023-02-27 | 2023-03-01 | $56.72 | $1.1M | +4.2% | +8.8% | +6.2% |
| NARI | SELL | 2023-01-27 | 2023-01-31 | $60.47 | $1.1M | -5.4% | -3.7% | +12.3% |
| NARI | SELL | 2022-12-27 | 2022-12-28 | $63.16 | $1.2M | +8.8% | -5.6% | +0.5% |
| NARI | SELL | 2022-11-28 | 2022-11-30 | $74.71 | $1.1M | -5.6% | -13.9% | -23.8% |
| NARI | SELL | 2022-10-27 | 2022-10-28 | $74.96 | $1.5M | -8.7% | -3.0% | -17.0% |
| NARI | SELL | 2022-03-28 | 2022-03-30 | $90.00 | $180K | -4.4% | -11.3% | -23.8% |
| NARI | SELL | 2022-02-28 | 2022-03-02 | $90.02 | $540K | -22.0% | -6.4% | -32.3% |
| NARI | SELL | 2021-11-29 | 2021-12-01 | $83.33 | $688K | -3.9% | +9.6% | +11.9% |
| NARI | SELL | 2021-10-27 | 2021-10-28 | $87.76 | $498K | -2.6% | -5.4% | -24.3% |
| NARI | SELL | 2021-09-27 | 2021-09-28 | $82.82 | $795K | -2.5% | +11.5% | +14.5% |
| NARI | SELL | 2021-08-27 | 2021-08-30 | $81.67 | $662K | -2.3% | -3.7% | +3.6% |
| NARI | SELL | 2021-07-27 | 2021-07-28 | $84.24 | $699K | +5.8% | -7.6% | -2.6% |
| NARI | SELL | 2021-06-28 | 2021-06-29 | $95.94 | $959K | -0.8% | -3.6% | -10.3% |
| NARI | SELL | 2021-05-27 | 2021-05-28 | $88.32 | $883K | +6.9% | +12.2% | -6.6% |
| NARI | SELL | 2021-04-27 | 2021-04-30 | $113.01 | $891K | -26.4% | -29.5% | -22.1% |
| NARI | SELL | 2021-03-26 | 2021-03-29 | $103.17 | $959K | +14.7% | +14.8% | -3.5% |
| NARI | SELL | 2021-02-26 | 2021-03-02 | $103.96 | $915K | +6.6% | +0.3% | -25.2% |
| NARI | SELL | 2021-01-27 | 2021-01-29 | $97.42 | $590K | +16.1% | +15.6% | +17.1% |
| NARI | SELL | 2021-01-20 | 2021-01-22 | $100.42 | $1.2M | -2.0% | +5.8% | -0.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.